Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Virtual Reality Application in Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03707210
Recruitment Status : Unknown
Verified July 2018 by Taipei Medical University.
Recruitment status was:  Not yet recruiting
First Posted : October 16, 2018
Last Update Posted : October 16, 2018
Sponsor:
Collaborator:
Taipei Medical University WanFang Hospital
Information provided by (Responsible Party):
Taipei Medical University

Brief Summary:
The present study wants to design a training program for chemotherapy with using VR. Then the investigators design a protocol to compare the training effects in the VR program and ISO document.

Condition or disease Intervention/treatment Phase
Chemotherapy Training Behavioral: VR training program Not Applicable

Detailed Description:
As technology advances, mobile devices have gradually turned into wearable devices. Furthermore, virtual reality (VR), augmented reality (AR), and mixed reality (MR) are being increasingly applied in medical fields such as medical education and training, surgical simulation, neurological rehabilitation, psychotherapy, and telemedicine. Research results demonstrate the ability of VR, AR, and MR to ameliorate the inconveniences that are often associated with traditional medical care, reduce incidents of medical malpractice caused by unskilled operations, and reduce the cost of medical education and training. What is more, the application of these technologies has enhanced the effectiveness of medical education and training, raised the level of diagnosis and treatment, improved the doctor-patient relationship, and boosted the efficiency of medical execution. The present study wants to design a training program for chemotherapy with using VR. Then the investigators design a protocol to compare the training effects in VR program and ISO document.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: intervention: VR training; control group: ISO document
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Virtual Reality Application in Chemotherapy
Estimated Study Start Date : October 15, 2018
Estimated Primary Completion Date : March 5, 2019
Estimated Study Completion Date : March 5, 2019

Arm Intervention/treatment
Experimental: Intervention
The experimental group uses the VR program to training chemotherapy skill. Use VR software to make a training education program.
Behavioral: VR training program
Use VR software to make a training education program.

No Intervention: usual care
Chemotherapy training as usual care (for training chemotherapy skill).



Primary Outcome Measures :
  1. The questionnaire about intervention effect [ Time Frame: After intervention 1 week, to perform the test. Including the content design, the convenience, the effectiveness, and promotion. ]
    After intervention, the investigator want to know the effect of intervention. A total of 12 questions, using the Likert's scale, very disagree(1) to very agree(5). It will compute a total score, score high means more effective.


Secondary Outcome Measures :
  1. The questionnaire of Knowledge level for chemotherapy technique [ Time Frame: Before the intervention, the investigator perform a pretest. After intervention 1 week, the investigator perform the post test. ]
    The questionnaire want to understand the Knowledge for chemotherapy operation skill before and after intervention. A total of ten questions, with scores ranging from 0 to 10 points. , score high means more correct.

  2. The questionnaire of Attitude for chemotherapy operation [ Time Frame: Before the intervention, the investigator perform a pretest. After intervention 1 week, the investigator perform the post test. ]
    The questionnaire want to understand the Attitude for chemotherapy operation skill before and after intervention. A total of ten questions, using the likert's scale, very disagree with 1 point, very agree with 5 points, total scores between 10 points and 50 points. , score high means more active.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. The staffs who require to implement chemotherapy skill in the hospital.
  2. Age over 20 years.

Exclusion Criteria:

1. Refuse to join the study.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03707210


Contacts
Layout table for location contacts
Contact: Tsai-Wei Huang +88627361661 ext 6350 tsaiwei@tmu.edu.tw

Sponsors and Collaborators
Taipei Medical University
Taipei Medical University WanFang Hospital
Investigators
Layout table for investigator information
Principal Investigator: Tsai-Wei Huang Taipei Medical University
Layout table for additonal information
Responsible Party: Taipei Medical University
ClinicalTrials.gov Identifier: NCT03707210    
Other Study ID Numbers: N201801073
N201801073 ( Registry Identifier: TMU-JIRB )
First Posted: October 16, 2018    Key Record Dates
Last Update Posted: October 16, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Supporting Materials: Study Protocol

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Taipei Medical University:
virtual reality
chemotherapy